NCT05394259View on ClinicalTrials.gov

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Pancreatic CancerBreast CancerHepatocellular Carcinoma
Interventions
DRUG

Piflufolastat F18

Given by vein (IV)

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Lantheus Medical Imaging
All Listed Sponsors
collaborator

Lantheus Medical Imaging

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER